NYSE:RMDMedical Equipment
How ResMed’s Record Results and Dividend Hike Will Impact RMD Investors
ResMed reported strong fourth quarter and full-year financial results, including sales of US$1.35 billion and net income of US$379.71 million for the quarter ended June 30, 2025, and simultaneously announced a quarterly dividend increase to US$0.60 per share.
The company's increased dividend and enhanced earnings per share reflect ResMed's confidence in its ongoing growth and commitment to delivering value to shareholders.
With the dividend increase highlighting ResMed's outlook, let’s...